In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.
Learning objectives:
Understand basic mechanisms of contrast induced kidney injury.
Determine incidence of disease along with long term patient and economic implications.
Review risk factors determining higher risk populations.
Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
Case review of use of the ACIST CVi Contrast Delivery System in high risk patient.
About our Sponsor:
ACIST Medical Systems - Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.
